Literature DB >> 21509500

Synthesis of highly substituted 2,3-dihydropyrimido[4,5-d]pyrimidin-4(1H)-ones from 4,6-dichloro-5-formylpyrimidine, amines and aldehydes.

Jinbao Xiang1, Chao Geng, Lang Yi, Qun Dang, Xu Bai.   

Abstract

A practical strategy was developed for the preparation of highly substituted 2,3-dihydropyrimido[4,5-d]pyrimidin-4(1H)-ones from 4,6-dichloro-5-formylpyrimidine, primary amines, and aldehydes. The key step for this synthesis entails a cyclization reaction involving an intramolecular amide addition to an iminium intermediate formed in situ from 4-amino-pyrimidine-5-carboxamide 2 and aldehydes to form the pyrimido[4,5-d]pyrimidine core with a strategically placed 5-Cl group for further derivatization. The utility of this methodology was demonstrated through the preparation of a 27-membered library of representative 2,3-dihydropyrimido[4,5-d]pyrimidin-4(1H)-ones in moderate to good yields.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21509500     DOI: 10.1007/s11030-011-9314-5

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  17 in total

1.  Stereochemistry as a tool in deciphering the processes of a tandem iminium cyclization and Smiles rearrangement.

Authors:  Jinbao Xiang; Tong Zhu; Qun Dang; Xu Bai
Journal:  J Org Chem       Date:  2010-11-09       Impact factor: 4.354

2.  Novel heterocyclic scaffold consisting of indole-fused pteridines.

Authors:  Lianyou Zheng; Jinbao Xiang; Qun Dang; Sigen Guo; Xu Bai
Journal:  J Comb Chem       Date:  2005 Nov-Dec

3.  Method development for a pyridobenzodiazepine library with multiple diversification points.

Authors:  Fuqiang Shi; Xianxiu Xu; Lianyou Zheng; Qun Dang; Xu Bai
Journal:  J Comb Chem       Date:  2008-02-09

4.  Kinase domain mutations in cancer: implications for small molecule drug design strategies.

Authors:  Jack A Bikker; Natasja Brooijmans; Allan Wissner; Tarek S Mansour
Journal:  J Med Chem       Date:  2009-03-26       Impact factor: 7.446

5.  A cascade reaction consisting of Pictet-Spengler-type cyclization and Smiles rearrangement: application to the synthesis of novel pyrrole-fused dihydropteridines.

Authors:  Jinbao Xiang; Lianyou Zheng; Feng Chen; Qun Dang; Xu Bai
Journal:  Org Lett       Date:  2007-02-06       Impact factor: 6.005

6.  Synthesis of novel tricyclic pyrimido[4,5-b][1,4]benzothiazepines via Bischler-Napieralski-type reactions.

Authors:  Renzhong Fu; Xianxiu Xu; Qun Dang; Xu Bai
Journal:  J Org Chem       Date:  2005-12-23       Impact factor: 4.354

7.  Design, synthesis, and structure-activity relationship of 6-alkynylpyrimidines as potent adenosine kinase inhibitors.

Authors:  Arthur Gomtsyan; Stanley Didomenico; Chih-Hung Lee; Mark A Matulenko; Ki Kim; Elizabeth A Kowaluk; Carol T Wismer; Joe Mikusa; Haixia Yu; Kathy Kohlhaas; Michael F Jarvis; Shripad S Bhagwat
Journal:  J Med Chem       Date:  2002-08-15       Impact factor: 7.446

8.  Lead optimization of N-3-substituted 7-morpholinotriazolopyrimidines as dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitors: discovery of PKI-402.

Authors:  Christoph M Dehnhardt; Aranapakam M Venkatesan; Efren Delos Santos; Zecheng Chen; Osvaldo Santos; Semiramis Ayral-Kaloustian; Natasja Brooijmans; Robert Mallon; Irwin Hollander; Larry Feldberg; Judy Lucas; Inder Chaudhary; Ker Yu; Jay Gibbons; Robert Abraham; Tarek S Mansour
Journal:  J Med Chem       Date:  2010-01-28       Impact factor: 7.446

9.  Resistance-modifying agents. 11.(1) Pyrimido[5,4-d]pyrimidine modulators of antitumor drug activity. Synthesis and structure-activity relationships for nucleoside transport inhibition and binding to alpha1-acid glycoprotein.

Authors:  Nicola J Curtin; Hannah C Barlow; Karen J Bowman; A Hilary Calvert; Richard Davison; Bernard T Golding; Bing Huang; Peter J Loughlin; David R Newell; Peter G Smith; Roger J Griffin
Journal:  J Med Chem       Date:  2004-09-23       Impact factor: 7.446

10.  Design, synthesis, and biological evaluation of 2,4-diamino-5-methyl-6-substituted-pyrrolo[2,3-d]pyrimidines as dihydrofolate reductase inhibitors.

Authors:  Aleem Gangjee; Xin Lin; Sherry F Queener
Journal:  J Med Chem       Date:  2004-07-01       Impact factor: 7.446

View more
  4 in total

1.  Synthesis and structure-activity relationship study of diaryl[d,f][1,3]diazepines as potential anti-cancer agents.

Authors:  Longjia Yan; Hui Wang; Yunpeng Chen; Zhiwei Li; Yazhong Pei
Journal:  Mol Divers       Date:  2018-01-03       Impact factor: 2.943

2.  Synthesis, X-ray and Fluorescence Characteristics of Pyrimido[5,4-e]thiazolo[3,2-a]pyrimidine as a Novel Heterocyclic System.

Authors:  Zahra Ebrahimpour; Mehdi Bakavoli; Ali Shiri; Seyed Mohammad Seyedi; Tayebe Asghari; Joel T Mague
Journal:  J Fluoresc       Date:  2017-03-10       Impact factor: 2.217

3.  Discovery of Novel Tricyclic Thiazepine Derivatives as Anti-Drug-Resistant Cancer Agents by Combining Diversity-Oriented Synthesis and Converging Screening Approach.

Authors:  Jinbao Xiang; Zhuoqi Zhang; Yan Mu; Xianxiu Xu; Sigen Guo; Yongjin Liu; Daniel P Russo; Hao Zhu; Bing Yan; Xu Bai
Journal:  ACS Comb Sci       Date:  2016-04-15       Impact factor: 3.784

Review 4.  Bicyclic 6 + 6 systems: the chemistry of pyrimido[4,5-d]pyrimidines and pyrimido[5,4-d]pyrimidines.

Authors:  M Monier; Doaa Abdel-Latif; Ahmed El-Mekabaty; Khaled M Elattar
Journal:  RSC Adv       Date:  2019-09-30       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.